Navigation Links
Simbionix USA Corporation Announces the Appointment of Mr. Paul Jensen as General Manager for its Growing eLearning and Content Business
Date:9/9/2009

CLEVELAND, Ohio and DENVER, Colorado, September 9 /PRNewswire/ -- Simbionix USA Corporation, a global leader in simulation and training products for clinical professionals, today announced the appointment of Mr. Paul Jensen as the new General Manager for Simbionix's eLearning and Content business.

Mr. Jensen is an information services executive with extensive experience in building innovative information products and services for a variety of professional markets including education and corporate training. He was responsible for the learning management system for Aplia, a leading Web-based homework solution for higher education, and he created the first eLearning product strategy for Thomson Learning. Most recently, Mr. Jensen held several senior management roles with Wolters Kluwer, a global leader in information services and publishing, including responsibility for enterprise-wide strategies and business priorities for online content delivery systems. He earned his MBA, with honors, from Columbia Business School.

"Over the previous four months we were involved in an intensive, nationwide recruitment process to find the ideal person to lead our growing eLearning and Content business, and we are very pleased to have Paul join Simbionix," said Gary Zamler, Simbionix's CEO. "In order to meet the growing training and performance improvement needs of our global customers, Simbionix now offers a full range of integrated training solutions including virtual reality simulations, online courseware and learning management systems under our MentorLearn(TM) umbrella of products and services. Paul's talent, proven leadership, experience in identifying global trends and commercializing new e-Learning products and services, as well as in the delivery of online content, will be another building block in Simbionix's exponential growth and success in these areas of the global training and performance improveme
'/>"/>

SOURCE Simbionix
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2

Related biology technology :

1. Simbionix and Johnson & Johnson LLC Announce a Distribution Agreement for Russia and the CIS Countries
2. Simbionix Increases Product Offerings for OB/GYN Physicians
3. Glen C. Williams Joins eLearning Sales Team for Simbionix, Heading up Chicago Office
4. New Colorectal Module From Simbionix Advances Laparoscopic Cancer Treatment
5. William E. Lewandowski to Lead Simbionix US Marketing Team in Simbionixs Strategic Expansion in the US Market
6. Simbionix Raises Largest Amount in Companys History in Venture Capital to Accelerate Growth
7. Simbionix Launches Innovative Patient-Specific Simulation
8. Simbionix Releases Powerful New Learning Management System With Enhanced True Assessment System(TM)
9. Simbionix Takes Non-Invasive GYN Surgical Training to the Next Level
10. 2007 a "Record Year" for Successful Validation Studies of Simbionix Simulators
11. eBioscience Corporation Acquires NatuTec GmbH
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/23/2014)... DES MOINES, Iowa (PRWEB) July 23, 2014 ... will join the business as vice president of Agricultural ... from Mendel Biotechnology where he served most recently as ... brings extensive biotechnology and business leadership in the seed ... DuPont Pioneer,” said Paul E. Schickler , president ...
(Date:7/23/2014)... 23, 2014 Shire plc ... global specialty biopharmaceutical company, and ArmaGen, a US ... licensing and collaboration agreement for AGT-182, an investigational ... of both the central nervous system (CNS) and ... II). This collaboration strengthens Shire,s rare disease pipeline ...
(Date:7/23/2014)... 2014 China Cord Blood Corporation (NYSE: CO ... provider of cord blood collection, laboratory testing, hematopoietic stem cell processing, ... multi-product healthcare company catering to the mother and child segment, today ... across the PRC, Singapore , Hong ... , the Philippines and ...
(Date:7/23/2014)... MD (PRWEB) July 23, 2014 a2z ... and ChirpE Mobile App, AACC Pathfinder, in its ... offerings. AACC’s annual meeting is planned for July 29-31, ... the place to be to connect with global leaders ... lab management, and other areas of breaking science in ...
Breaking Biology Technology:DuPont Pioneer Names Neal Gutterson to Lead Agricultural Biotechnology 2DuPont Pioneer Names Neal Gutterson to Lead Agricultural Biotechnology 3Shire Enters Strategic Licensing and Collaboration Agreement With ArmaGen 2Shire Enters Strategic Licensing and Collaboration Agreement With ArmaGen 3Shire Enters Strategic Licensing and Collaboration Agreement With ArmaGen 4Shire Enters Strategic Licensing and Collaboration Agreement With ArmaGen 5China Cord Blood Corporation and Cordlife Group Limited Announce Collaboration to Aid Asia-based Patients with Cord Blood Stem Cell Therapy 2China Cord Blood Corporation and Cordlife Group Limited Announce Collaboration to Aid Asia-based Patients with Cord Blood Stem Cell Therapy 3China Cord Blood Corporation and Cordlife Group Limited Announce Collaboration to Aid Asia-based Patients with Cord Blood Stem Cell Therapy 4AACC Enhances Attendee Experience at Its 2014 Annual Meeting & Clinical Lab Expo with a2z-Powered ChirpE Photo Booth and Mobile App 2AACC Enhances Attendee Experience at Its 2014 Annual Meeting & Clinical Lab Expo with a2z-Powered ChirpE Photo Booth and Mobile App 3
... May 26, 2010 , , ... - Study Data Shows ORMD-0801 Resulted in Glucose and C-Peptide Reduction , ... Oramed Pharmaceuticals Inc. (OTCBB: ORMP.OB) ( ... study to assess the safety and pharmacodynamics,of five oral insulin formulations in healthy subjects," ...
... 26 /PRNewswire-FirstCall/ - Oncolytics Biotech Inc. ("Oncolytics") (TSX:ONC, ... & Research Center at the University of Texas ... (CTRC) has started patient enrolment in a U.S. Phase ... combination with gemcitabine (Gemzar(R)) in patients with advanced pancreatic ...
... LONDON , May 26 ... announces the issuance of United States patent ... Treatment of Cancer and Other Neovascularization Disease, by the ... patent, which deepens the Company,s diverse portfolio of RNA ...
Cached Biology Technology:Oramed Pharmaceuticals Announces Publication of Research Article on its Oral Insulin Capsule ORMD-0801 in Diabetes, Obesity and Metabolism 2Oramed Pharmaceuticals Announces Publication of Research Article on its Oral Insulin Capsule ORMD-0801 in Diabetes, Obesity and Metabolism 3Oncolytics Biotech(R) Inc. Announces Start of Enrolment in U.S. Phase 2 Pancreatic Cancer Clinical Trial 2Oncolytics Biotech(R) Inc. Announces Start of Enrolment in U.S. Phase 2 Pancreatic Cancer Clinical Trial 3Oncolytics Biotech(R) Inc. Announces Start of Enrolment in U.S. Phase 2 Pancreatic Cancer Clinical Trial 4Silence Therapeutics Issued Novel RNAi Patent Covering High-Value Cancer Target in United States 2Silence Therapeutics Issued Novel RNAi Patent Covering High-Value Cancer Target in United States 3Silence Therapeutics Issued Novel RNAi Patent Covering High-Value Cancer Target in United States 4
(Date:7/23/2014)... BOSTON , July 23, 2014 ... and threat detection, announced today it has been named ... . The Market Guide replaces Gartner,s well-known Magic Quadrant ... Gartner categorized BioCatch as one of several vendors to ... biometric analysis will become a standard feature of at ...
(Date:7/23/2014)... -- The potential for clinical use of induced ... strategies has previously been hindered by the risk ... tumors. The ability to use etoposide treatment to ... of heart disease, specifically acute myocardial infarction, is ... and Development , a peer-reviewed journal from Mary ...
(Date:7/23/2014)... Springer will publish the International Journal of Fuzzy ... the Taiwan Fuzzy Systems Association (TFSA). The cooperation will ... the area of fuzzy research., The International Journal ... papers that deal with the theory, design and application ... extension theory systems ranging from hardware to software. Launched ...
Breaking Biology News(10 mins):BioCatch Featured in Gartner's 2014 Online Fraud Detection Market Guide 2BioCatch Featured in Gartner's 2014 Online Fraud Detection Market Guide 3
... think a city would provide a good home for bats ... buildings. But researchers at the University of Calgary made the ... for these animals. "I was really surprised," says Dr. ... biological sciences at the University of Calgary and lead author ...
... CHAMPAIGN, lll. Blood clotting is a complicated business, ... to injury. In a new study, researchers report that they ... interaction that is vital to blood clotting. This interaction ... baffled scientists for decades. The study appears ...
... State University shows that so-called biodegradable products are likely ... are releasing a powerful greenhouse gas as they break ... utensils, are broken down in landfills by microorganisms that ... a paper describing the research and professor and head ...
Cached Biology News:Big city holds empty promise for bats 2Team solves decades-old molecular mystery linked to blood clotting 2Team solves decades-old molecular mystery linked to blood clotting 3Study: Biodegradable products may be bad for the environment 2
... description: self locking design in ice/water ... new product number, created to easily ... no availability yet, please order under ... contact customer service for assistance. ID ...
Membrane Proteins from over 50 different human Alzheimer, Diabetic, Liver Cirrhosis, and Lupus diseased tissues are available....
... This CLS number is ... to easily match Cornings product ... yet, please order under the ... contact customer service for assistance. ...
This modular laminar flow hood forces air through a 99.99% efficient HEPA filter to create a clean processing area. Configurations are available with vertical or horizontal flow; options include a wo...
Biology Products: